1. Home
  2. Stock quotes
  3. Bristol-Myers Squibb Company
  4. Financial Statements
  5. Balance Sheet
  6. Deferred Revenue
Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
$ 58.36 -0.56%
mail-toReport an Error

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Bristol-Myers Squibb Company Deferred Revenue 2011-2024 | BMY

Annual Deferred Revenue Bristol-Myers Squibb Company

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 510 M 172 M 83 M 762 M 1 B 1.17 B 756 M 825 M 337 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.17 B 83 M 624 M

Quarterly Deferred Revenue Bristol-Myers Squibb Company

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency